FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting You may have seen headlines recently claiming peptides like MOTS C or BPC 157 are back let's talk about what this means. In 2023, the FDA placed 19 commonly used peptides into Category When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies